The Use of FluorescenceIn SituHybridization (FISH) in Chronic Lymphocytic Leukemia (CLL)
Alessandro Gozzetti, Rosaria Crupi, Daniela Tozzuoli
Abstract
Open-access reader
Alessandro Gozzetti, Rosaria Crupi, Daniela Tozzuoli
Abstract
Open-access reader
As a result of the low proliferative index, only 50% of chronic lymphocytic leukemia cases are adequate for cytogenetic analysis. Of these, about half have clonal abnormalities. The application of fluorescence in situ hybridization (FISH) to CLL has substantially enhanced our ability to detect chromosomal aberrations; the incidence of a number of recurring abnormalities has been established, providing new insights into the pathogenesis of this disease with a direct impact on the prognosis.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
As a result of the low proliferative index, only 50% of chronic lymphocytic leukemia cases are adequate for cytogenetic analysis. Of these, about half have clonal abnormalities. The application of fluorescence in situ hybridization (FISH) to CLL has substantially enhanced our ability to detect chromosomal aberrations; the incidence of a number of recurring abnormalities has been established, providing new insights into the pathogenesis of this disease with a direct impact on the prognosis.
Key concepts: Chronic lymphocytic leukemia, Fluorescence in situ hybridization, In situ hybridization, Pathogenesis, Fish <Actinopterygii>, Biology, In situ, Leukemia